Back to Financial results
		ARVIND REMEDIES LIMITED
		AUDITED FINANCIAL RESULTS FOR THE YEAR ENDED 31-03-2009
						(Rupees in Lakhs)
	Sl No	Particulars	Nine Month Ended	<----Quarter Ended------->		<---For the year ended-->
			31.12.2008	31.03.2009	31.03.2008	31.03.2009	31.03.2008
				(Audited)	(Audited)	(Audited)	(Audited)
	1	Net Income from Sales	########	5,892.29	4,806.63	21788.84	17567.15
	2	Other Operating Income	2.09	1.14	3.05	3.23	3.05
	3	TOTAL INCOME	15898.64	5893.43	4809.68	21792.07	17570.20
	4	Cost of Sales:
		a) (Increase)/Decrease in stock	50.16	(64.89)	(266.19)	(14.73)	(435.01)
		b)  Consumption of Materials	########	4,961.45	4,342.01	18,492.78	15,283.14
		c)  Purchase of Traded Goods	106.18	129.11	30.69	235.29	30.69
		d)  Employee Cost	323.74	169.17	154.63	492.91	441.04
		e)  Other expenditure	227.94	2.8	12.57	230.74	223.10
		Total (a) to (e)	14239.35	5197.64	4273.71	19436.99	15542.96
	5	Gross Profit (4-3)	1659.29	695.79	535.97	2355.08	2027.24
	6	General Administration Expenses	100.25	22.38	27.32	122.63	150.37
	7	Selling and Distribution Expenses	126.85	127.11	107.63	253.96	276.40
	8	Depreciation	147.47	46.13	46.79	193.60	179.71
	9	Operating Profit before Interest	1284.72	500.17	354.23	1784.89	1420.76
	10	Interest	626.49	521.50	243.09	1,147.99	748.02
	11	Execptional Items		-	-	0.00	0.00
	12	Operating Profit after Interest and Exceptional Items(9-10-11)	658.23	-21.33	111.14	636.90	672.74
	13	Other Income	10.20	70.00	5.57	80.20	16.61
	14	Profit from Ordinary activities Before  Tax(12+13)	668.43	48.67	116.71	717.10	689.35
	15	Tax Expenses
		Current Tax	90.00	12.80	67.56	102.80	147.56
		Deferred Tax	7.70	124.97	56.09	132.67	29.11
	16	Net Profit from Ordinary activities after Tax(14-15)	570.73	(89.10)	(6.94)	481.63	512.68
	17	Extraordinary Items (net of tax expense)	-	-	-	-	-
	18	Net Profit for the Period	570.73	(89.10)	(6.94)	481.63	512.68
	19	Paid-up EquityShareCapital ( FaceValueRe.1 / share)	2,600.50	2,600.50	2,600.50	2600.50	2600.50
	20	Reserves excluding Revaluation Reserve				2211.37	1881.87
	21	Earnigs per Share(EPS):                                      Basic and Diluted EPS before and after extraordinary Items - (Rs.)	0.22	--		0.19	0.20
	22	Public Shareholding
		Number of shares	1.94E+08	194205340		194205340
		Percentage of Shareholding	74.68%	74.68%		74.68%
	23	Promoters and Promoter Group shareholding -
		a) Pledged / encumbered
		- No of Shares	Nil	Nil		Nil
		- Percentage of shares(as % of total	--	--		--
		shareholding of promoters and promoter group)
		- Percentage of shares(as % of total  capital)	--	--		--
		a) Non-encumbered
		- No of Shares		65844660		65844660
		- Percentage of shares(as % of total		100.00%		100.00%
		shareholding of promoters and promoter group)
		- Percentage of shares(as % of total  capital)		25.32%		25.32%
	Notes:
	1	The above results were reviewed by the audit committee and  taken on record at the meeting of the Board of Directors held on May 30, 2009
	2	The Board of Directors have recommended a dividend on Equity Shares @ 5 paise per share subject to the approval of Members.
	3	Board also decided that
		(a)  due to changes in the fiscal policies, the  benefits available on the Haridwar unit have been substantially reduced.  Hence, it has been decided not to pursue with the Haridwar project. ,
		(b) for the proposed new project at Chennai, the project feasbility be obtained and placed in the next Board meeting for decision.  The funding of the project will also be discussed in that meeting.
		(c) the date of AGM and the book closure dates be finalised in the next Board Meeting.
	4	During the quarter 12 Investor Compliants were received and disposed of.  There were no Investor Compliants pending for the redressal as at the commencement and end of the quarter.
	5	Previous period's figures have been regrouped/ rearranged wherever necessary to confirm to the current period's classification.
		Chennai - 600 084			For ARVIND REMEDIES LTD
		Date:  30-05-2009
					DR.B.Arvind Shah
					CEO & Managing Director
							Back to Financial results